MURINE T-HELPER CELL-2 LYMPHOCYTES EXPRESS TYPE-I AND TYPE-II IL-1 RECEPTORS, BUT ONLY THE TYPE-I RECEPTOR MEDIATES COSTIMULATORY ACTIVITY

被引:0
|
作者
MCKEAN, DJ
PODZORSKI, RP
BELL, MP
NILSON, AE
HUNTOON, CJ
SLACK, J
DOWER, SK
SIMS, J
机构
[1] IMMUNEX RES & DEV CORP,DEPT MOLEC BIOL,SEATTLE,WA 98101
[2] IMMUNEX RES & DEV CORP,DEPT BIOCHEM,SEATTLE,WA 98101
来源
JOURNAL OF IMMUNOLOGY | 1993年 / 151卷 / 07期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of IL-1 in augmenting the Ag receptor-initiate activation program was evaluated in IL-4-producing (Th2) CD4+ murine T lymphocytes. Northern blot and I-125-labeled IL-1alpha cross-linking analyses demonstrated that Th2 lymphocytes express both type I and type II IL-1R. The expression of both IL-1R isoforms on the surface of the Th2 cells is coordinately up-regulated in response to anti-CD3 cross-linking in the absence of detectable accessory cells. Analyses of the kinetics of IL-1R acquisition demonstrated that the peak level of type I and type II IL-1R mRNA expression occurs after the peak expression of mRNA encoding IL-2Ralpha and IL-4, which are two IL-1-responsive events in the Th2 activation program. Type I IL-1 R ligand-binding antagonists, IL-1R antagonist and anti-type I mAb, were used to evaluate the functional significance of Th2 cell expression of two IL-1R isoforms. The addition of either IL-1R antagonist or anti-type I mAb completely inhibited the IL-1alpha-augmented component of the proliferative response stimulated by anti-CD3 plus exogenous IL-1alpha. Together, these studies indicate that, although Th2 clones express inducible levels of both type I and type II IL-1R isoforms, the IL-1-induced intracellular signals involved in augmenting an anti-CD3-stimulated proliferative response are mediated solely through the type I IL-1R.
引用
收藏
页码:3500 / 3510
页数:11
相关论文
共 50 条
  • [21] DETERMINATION OF TYPE-I RECEPTOR SPECIFICITY BY THE TYPE-II RECEPTORS FOR TGF-BETA OR ACTIVIN
    EBNER, R
    CHEN, RH
    LAWLER, S
    ZIONCHECK, T
    DERYNCK, R
    SCIENCE, 1993, 262 (5135) : 900 - 902
  • [22] STRUCTURAL ASPECTS OF IL-1 BINDING TO THE TYPE-I HUMAN IL-1 RECEPTOR
    YOUNG, PR
    EINSTEIN, R
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 84 - 84
  • [23] INHIBITION OF MURINE OSTEOGENIC SARCOMAS BY TREATMENT WITH TYPE-I OR TYPE-II INTERFERON
    CRANE, JL
    GLASGOW, LA
    KERN, ER
    YOUNGNER, JS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1978, 61 (03) : 871 - 874
  • [24] NORADRENERGIC REGULATION OF TYPE-I AND TYPE-II CORTICOSTEROID RECEPTORS IN AMYGDALA AND HYPOTHALAMUS
    MACCARI, S
    PIAZZA, PV
    ROUGEPONT, F
    ANGELUCCI, L
    SIMON, H
    LEMOAL, M
    BRAIN RESEARCH, 1992, 587 (02) : 313 - 318
  • [25] EXERCISE ENDURANCE IN RATS - ROLES OF TYPE-I AND TYPE-II CORTICOSTEROID RECEPTORS
    DEVENPORT, L
    DOUGHTY, D
    HEIBERGER, B
    BURTON, D
    BROWN, R
    STITH, R
    PHYSIOLOGY & BEHAVIOR, 1993, 53 (06) : 1171 - 1175
  • [26] PHYSICAL SEPARATION OF AORTIC CORTICOID RECEPTORS WITH TYPE-I AND TYPE-II SPECIFICITIES
    NICHOLS, NR
    NGUYEN, HH
    MEYER, WJ
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1985, 22 (05): : 577 - 582
  • [27] DIFFERENTIAL ONTOGENY OF TYPE-I AND TYPE-II BENZODIAZEPINE RECEPTORS IN MOUSE CEREBELLUM
    BACON, E
    DEBARRY, J
    GOMBOS, G
    DEVELOPMENTAL BRAIN RESEARCH, 1991, 58 (02): : 283 - 287
  • [28] THE DEVELOPMENT OF TYPE-I AND TYPE-II BENZODIAZEPINE RECEPTORS IN THE MOUSE CORTEX AND CEREBELLUM
    GARRETT, KM
    TABAKOFF, B
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 22 (06) : 985 - 992
  • [29] HUMAN SYNOVIAL FIBROBLASTS COEXPRESS IL-1 RECEPTOR-TYPE-I AND TYPE-II MESSENGER-RNA - THE INCREASED LEVEL OF THE IL-1 RECEPTOR IN OSTEOARTHRITIC CELLS IS RELATED TO AN INCREASED LEVEL OF THE TYPE-I RECEPTOR
    SADOUK, M
    PELLETIER, JP
    TARDIF, G
    KIANSA, K
    CLOUTIER, JM
    MARTELPELLETIER, J
    LABORATORY INVESTIGATION, 1995, 73 (03) : 347 - 355
  • [30] TYPE-I AND TYPE-II PSORIASIS SHOW A SIMILAR USAGE OF T-CELL RECEPTOR VARIABLE REGIONS
    SCHMITTEGENOLF, M
    BOEHNCKE, WH
    CHRISTOPHERS, E
    STANDER, M
    STERRY, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (06) : 1053 - 1056